By ChIP with chromatin from MDA-MB231 breast cancer cells, we could show that endogenous ZEB1 binds to the native promoter region of EPCAM that has five putative binding sites (E-boxes 1–4 and Z-Box-1) for ZEB1. This evidence concerns the gene ZEB1 and breast carcinoma.